Patients and physicians must be willing to comply with treatment assignment:
The subject is willing and able to abide by the protocol
Is willing and able to remain confined in the study unit for the entire duration of each treatment period and comply with restrictions related to food, drink and medications
Willing to comply with clinical trial instructions and requirements, including mandatory biopsies
Patients willing to comply with study requirements
Must be able to comply with the study and follow-up requirements
If premenopausal, patient must be willing to comply with pregnancy requirements
ADJUVANT COHORT: If premenopausal, patient must be willing to comply with pregnancy requirements
Patient able and willing to comply with study procedures as per protocol
Be able to comply with the requirements of the entire study.
Be willing to comply with clinical trial instructions and requirements.
Be willing to comply with clinical trial instructions and requirements, including mandatory biopsies.
Patients >= 18 years must be willing to comply with the mandatory biopsies.
Patient willing to conform to the study requirements
Willing and able to participate in the trial and comply with all trial requirements.
Subject is able to understand and willing to comply with protocol requirements and instructions
Patients must be able to comply with all protocol requirements
Willing and able to comply with study requirements for follow-up
Are willing and able to comply with the protocol requirements
Subject is able to understand and comply with protocol requirements and instructions
Subjects are willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
Patient must be able and willing to comply with study procedures as per protocol
Able to comply with the study protocol, in the investigator’s judgment
Be willing to comply with treatment protocol
Able to comply with study protocol, in the investigator’s judgment
Patients willing to comply with the clinical trial protocol
Subject is able to understand and willing to comply with protocol requirements and instructions
Must understand and be able, willing, and likely to fully comply with study procedures and restrictions.
Be willing to comply with treatment protocol
Patients who cannot comply with the study requirements
Be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.
Be willing to participate in the study and comply with all study requirements
Participants must be able to understand and willing to comply with protocol requirements as assessed by the investigator.
Subject is, in the investigator’s opinion, willing and able to comply with the protocol requirements
DONOR: Able and willing to comply with the requirements of the protocol
Be willing and able to comply with this protocol
Subject is able and willing to comply with the requirements of the protocol.
Willing and able to comply with all study requirements, including treatment, and attending required assessments
Willing and able to comply with all study procedures
Must be willing and able to comply with study
The subject is able to understand and comply with protocol requirements, timetables, instructions and protocol-stated restrictions
Participant must be willing and comply with the requirements of the protocol
Patient is willing and able to comply with protocol required assessments and procedures
Patients willing and able to comply with the study protocol for the duration of the study
Be able to comply with the requirements of the entire study.
Willing to comply with study procedures
Able and willing to comply with testing and treatment as outlined in this protocol
Patients who cannot comply with medications
Patient able and willing to comply with study procedures as per protocol
Patients must be able to comply with the protocol treatments and procedures.
Subject is willing and able to comply with the protocol for the duration of the study
Willing and able to comply with all study requirements, including treatment, timing and nature of required assessments
Patients must agree/be able to comply with all protocol specific requirements
Able to comply with the study protocol, in the investigator’s judgment
Subjects is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee
Are able and willing to comply with all study procedures.
The subject must be willing and have an understanding and ability to fully comply with study procedures and restrictions defined in the protocol.
Patient must be able and willing to comply with study procedures as per protocol
Medically and psychologically able to comply with all study requirements
Medically and psychologically able to comply with all study requirements
Able and willing to comply with study criteria
Willing and able to comply with all study procedures
Willing and able to comply with study procedures
Willing to comply with study procedures
Be willing to comply with effective antiretroviral therapy (ARV)
Willing and able to comply with all study requirements, including treatment and required assessments
Patients must meet the following criteria on screening examination to be eligible to participate in the study; all laboratory assessments should be performed within 21 days of initiation of protocol therapy unless otherwise specified; subject is, in the investigator’s opinion, willing and able to comply with the protocol requirements
Patient is willing and able to participate in the study and comply with all study requirements.
The patient is able and willing to comply with all study related procedures
Patient must be willing to comply with study procedures
Individuals not willing to comply with the procedural requirements of this protocol
Individuals not willing to comply with the procedural requirements of this protocol
Patients must be willing and able to comply with study and/or follow-up procedures
able to comply with all study-related procedures, medication use, and evaluations.
Patients who, for any reason, are not able to comply with the national legislation
Patients who, for any reason, are not able to comply with the national legislation.
Must be able to comply with study and follow up requirements
Patients must be willing to comply with effective Antiretroviral Therapy.
Willing and able to understand the nature of this study and to comply with the study and follow-up procedures.
Be willing to comply with the protocol.
Willing and able to participate in the trial and comply with all trial requirements.
Participant is willing and able to comply with the requirements of the protocol
Willing and able to participate in the trial and comply with all trial requirements
Participant is willing and able to comply with the requirements of the protocol
Subject is willing and able to comply with the requirements of the protocol.
Subject is unlikely to comply with the protocol requirements, instructions and study-related restrictions
Patients must be willing to comply with study procedures
Subject is able to understand and comply with protocol requirements and instructions
Willing and able to participate in the trial and comply with all trial requirements.
Be willing and able to comply with the protocol
The patient must be willing and able to comply with study requirements, remain at the clinic, and be willing and able to return to the clinic for the follow-up evaluation as specified in this protocol during the study period.
Patient must be willing and able to comply with the study procedures and visit schedules and must be able to follow verbal and written instructions.
Patient able and willing to comply with study procedures as per protocol, including the geriatric assessment at the time of study enrollment
Subject must be willing to comply with all procedures and assessments.
Able and willing to comply with all study procedures.
Able and willing to comply with protocol requirements, in the opinion of the investigator.
Is the subject willing and able to abide by the protocol?
Must be able to understand and comply with protocol requirements and instructions
Patients must be informed of the Celgene Risk Management Program and mandatory registration as well as be willing and able to comply with its requirements
Subject is able and willing to comply with the requirements of the protocol.
Participant is willing and able to comply with the requirements of the protocol
In order to obtain lenalidomide, patients must be registered into the mandatory RevlimidREMS program during the maintenance phase of therapy, and be willing and able to comply with the requirements of RevlimidREMS
Able to understand and comply with the requirements of the protocol
Willing and able to comply with the protocol guidelines for the duration of the study
Willing and able to meet all study requirements
Patients who are not able to comply with study and/or followup procedures
Patients must be willing to spend time for the study.
Be willing and able to adhere to all study-related procedures
Willing and able to do all study requirements
Able and willing to comply with all study related procedures
Willing to comply with study procedures and reporting requirements
Not willing to comply with study procedures and reporting requirements
Subject is willing and able to comply with the follow-up regimen
Willing to comply with all study procedures and be available for the duration of the study.
Willing and able to meet all study requirements
Patients who are able to comply with the anti-emetic therapy
Willing to comply with study procedures and reporting requirements
Not willing to comply with study procedures and reporting requirements
Are willing and able to complete study requirements
Subjects, who in the opinion of the investigator, may not be able to comply with study procedures
Willing and able to meet all study requirements
Able and willing to give informed assent and comply with study requirements
Willing and able to meet all study requirements
Willing and able to comply with the requirements of the protocol
Patient is able to understand and comply with protocol requirements and instructions
The subject is willing and able to comply with the study protocol
Able to co-operate with the investigator and to comply with the requirements of the entire study.
Participant is willing to be randomized and able to comply with the protocol
Willing and able to comply with trial protocol and follow-up
Willing and able to comply with trial protocol and follow-up
Willing and able to comply with trial protocol and follow-up
Willing and able to comply with trial protocol and follow-up
Be conscious and able to comply with study procedures
Subject must be willing to comply with all clinical study procedures
Willing to comply with all study procedures and be available for the duration of the study
Willing to comply with protocol requirements
PATIENT: Be able to comply with study procedures
Subject deemed unlikely to be able to comply with instructions during imaging
Patient is willing to comply with protocol requirements
Willing and able to follow the protocol requirements.
Willing to comply with all study procedures and be available for the duration of the study.
Not willing to comply with the procedural requirements of this protocol
Women willing to comply with protocol requirements
Patients willing to comply with protocol requirements
The patient is willing and able to comply with the study protocol
Capable and willing to comply with the entire study protocol
Patients not able to comply with the study procedures
Are willing and able to comply with study procedures and instructions, including completion of diaries.
Willing and able to comply with all study procedures
Patients who are able to comply with the protocol.